Press release
Post-Traumatic Stress Disorder Therapeutics Market Size Projected To Reach $1.38 Billion By 2034 With A Cagr Of 3.8%
Post-Traumatic Stress Disorder Therapeutics
What Is the Post-Traumatic Stress Disorder Therapeutics Market Size and Projected Growth Rate?
The market size for therapeutics in post-traumatic stress disorder has seen a consistent rise in the recent past. A growth from $1.14 billion in 2024 to $1.19 billion in 2025 is forecasted, at a compound annual growth rate (CAGR) of 4.9%. The surge during the historical phase can be credited to heightened awareness, rise in trauma cases, government endeavours, enhanced diagnostic tools, reduced stigma, psychological aid programs, and emphasis on veterans' healthcare.
The market size of therapeutics for post-traumatic stress disorder is projected to experience consistent growth in the upcoming years, reaching a value of $1.38 billion in 2029, growing at a compound annual growth rate (CAGR) of 3.8%. This growth during the projected period can be linked to factors such as increased availability of mental health services, policies pertaining to mental health by the government, progress in biological and neurological research, prevalence of PTSD in civilian population, and crisis response strategies. The forecast period will likely see pivotal trends such as the incorporation of digital therapeutics, new developments in pharmacological therapies, techniques in neurostimulation and brain stimulation, psychedelic-facilitated treatment, and collaborative research initiatives.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9214
What Are the Different Post-Traumatic Stress Disorder Therapeutics Market Segments?
The post-traumatic stress disorder therapeutics market covered in this report is segmented -
1) By Drug Class: Antidepressants, Anti-Anxiety, Antihypertensive, Monoamine Oxidase (MAOs), Antipsychotics Or Second Generation Antipsychotics (SGOs), Beta-Blockers, Other Classes
2) By Age Group: Pediatric, Geriatric, Adult
3) By End User: Mental Health Center, Hospitals, Outpatient Clinics, Other End Users
Subsegments:
1) By Antidepressants: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
2) By Anti-Anxiety: Benzodiazepines, Buspirone
3) By Antihypertensive: Prazosin, Clonidine
4) By Monoamine Oxidase Inhibitors (MAOs): Traditional MAOIs, Reversible MAOIs
5) By Antipsychotics (Second Generation Antipsychotics - SGOs): Risperidone, Quetiapine
6) By Beta-Blockers: Propranolol, Atenolol
7) By Other Classes: Mood Stabilizers, Adjunctive Therapies
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9214&type=smp
What Are the Primary Drivers Shaping the Post-Traumatic Stress Disorder Therapeutics Market?
The escalation in the prevalence of cases of post-traumatic stress disorder (PTSD) worldwide is set to stimulate the progress of the post-traumatic stress disorder therapeutics market. PTSD, as it's commonly known, is a condition that afflicts individuals who have been exposed to terrifying, horrifying, or perilous scenarios. Treatment methods for PTSD like psychotherapy and medication assist individuals in regaining authority over their lives. To illustrate, the Ministry of Defence, Department of Community Mental Health - a UK-based enterprise that supplies mental health services to active service members and reservists - recorded that, in March 2024, the figure of military personnel needing initial PTSD evaluations from a professional mental health clinician surged from 266 cases in 2022 to 320 cases in 2023, representing an appreciable increase in recorded cases. Therefore, the increasing incidence of post-traumatic stress disorder (PTSD) cases is propelling the growth of the post-traumatic stress disorder therapeutics market.
Which Companies Are Leading in the Post-Traumatic Stress Disorder Therapeutics Market?
Major companies operating in the post-traumatic stress disorder therapeutics market include Pfizer Inc., GlaxoSmithKline plc, Bionomics Limited, Otsuka Pharmaceutical Co Ltd., Eli Lilly and Company, AstraZeneca plc, Tonix Pharmaceuticals Holding Corp., Freespira Inc., MicroTransponder Inc., Compass Pathways plc, Boehringer Ingelheim International GmbH, Halucenex Life Sciences Inc., Bionorica SE, MAPS Europe BV, Hoffmann-La Roche Ltd., Praxis Precision Medicines Inc., H Lundbeck A/S, Johnson & Johnson, Sanofi SA, Takeda Pharmaceutical Company Limited, Merck KGaA, Jazz Pharmaceuticals plc
What Are the Major Trends Shaping the Post-Traumatic Stress Disorder Therapeutics Market?
Strategic partnerships, financial support and investments have become a significant trend in the post-traumatic stress disorder therapeutic market. To enhance their market presence, major companies in the industry are establishing strategic partnerships and investing in other firms. A notable example was in January 2022, when professor Dan Lubman AM, Dr. Shalini Arunogiri, and Dr. Paul Liknaitzky from Monash University, part of an interdisciplinary research group, received more than $1.9 million to research the efficiency of MDMA-assisted psychological therapy for alcohol use disorder (AUD) and post-traumatic stress disorder (PTSD). This project is one of seven clinical trials recently announced by the Federal government under the Medical Research Future Fund (MRFF) to assess the potential of innovative combination treatments for severe mental illnesses.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/post-traumatic-stress-disorder-therapeutics-global-market-report
What Are the Top Revenue-Generating Geographies in the Post-Traumatic Stress Disorder Therapeutics Market?
North America was the largest region in the post-traumatic stress disorder therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-traumatic stress disorder therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Post-Traumatic Stress Disorder Therapeutics Market?
2. What is the CAGR expected in the Post-Traumatic Stress Disorder Therapeutics Market?
3. What Are the Key Innovations Transforming the Post-Traumatic Stress Disorder Therapeutics Industry?
4. Which Region Is Leading the Post-Traumatic Stress Disorder Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Post-Traumatic Stress Disorder Therapeutics Market Size Projected To Reach $1.38 Billion By 2034 With A Cagr Of 3.8% here
News-ID: 3980521 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Stress
Leading Element Driving Change in the Stress Toy Market in 2025: Rising Stress A …
What Is the Estimated Market Size and Growth Rate for the Stress Toy Market?
In recent years, there has been a significant expansion in the stress toy market. The market, which was valued at $5.52 billion in 2024, is projected to increase to $5.88 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. Several factors have contributed to growth during this historical period, including a higher incidence of…
Key Driver Reshaping the Stress Tracking Devices Market in 2025: Rising Stress-R …
"What Are the Projections for the Size and Growth Rate of the Stress Tracking Devices Market?
The market size for stress tracking devices has seen significant expansion in the past few years. Projected growth is from $3.14 billion in 2024 to $3.43 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.3%. The key factors that have contributed to growth over the historical period include the upsurge in stress-related…
Stress Testing Solutions Market Exploring Opportunities in Macroprudential Stres …
Increase in demand for mobile applications with advanced features is expected to drive the stress testing solutions market considerably in next few years. In addition, factors such as rise in adoption of mobile devices, need to ensure systems can handle extreme workloads, and adoption of test automation services are expected to majorly drive growth of the market. However, data management & data quality issues and uncertainties about easy availability of…
Stress Management 2023
Globally, the COVID-19 pandemic affected not only the financial status but also the mental health of the individuals drastically which increased the stress management market to USD 18,700.9 million and expected to increase at a CAGR of 3.8% during the forecast period. Globally, 10% of the children encounter any least one of the mental disorders. The preliminary treatment could be discussing the issue with the cherished circle, whereas professional…
Agrow Plant Stress Products
ReportsWorldwide has announced the addition of a new report title Agrow Plant Stress Products 2016 to its growing collection of premium market research reports.
Abiotic stresses such as heat, cold and drought prevent crops from reaching their full potential productivity. Plant stress products are a new category, increasing the tolerance of crop plants to these and other adverse environments. They span conventional pesticides with ‘crop enhancement’ or ‘plant health’ promoting properties,…
National Stress Awareness Day
National Stress Awareness Day is on Wednesday 5th November 2014. Relaxa is offering employee stress & wellbeing health promotion packages starting at £255 on or around this date - incorporating a range of stress & wellbeing activities for your staff.
There are 9 cost-effective stress and wellbeing promotion packages available below:
1) Stress Health Promotion Package 1 - £255.00+vat
2) Stress Health Promotion Package 2 - £399.00+vat
3) Stress Health Promotion Package 3…
